| Sven V Eriksson. MD, PhD, Ass. Professor
Department of Medicine Danderyd Hospital 182 88 Danderyd Sweden Fax: +46 8 622 68 10 E-mail: svemed@pi.se |
![]() |
NEW (Oct 16, 2003) Powerpoint files: Vectorcardiography and Cardiac enzymes during Dialysis.
Just RIGHT click on the point and choose "download target as".
New Powerpoint presentation. Lipid lowering treatments.
Just click on this point or here to view this Power Point presentation on line.(Works with Internet Explorer or Netscape/Mozilla)
Feb 24 2006 most recent Powerpoint presentation.Kloka listan
Just click
on this point or here to view this Power Point presentation on line.(Works
with Internet Explorer or Netscape/Mozilla)
Current research interests:
| Vectorcardiography in ischemic heart disease. |
We have a long experience in using continuous on-line vectorcardiography (VCG) in
patients with ischemic heart disease (IHD). Nearly all patients, admitted to the CCU have
24-hour VCG registrations. The clinical usefulness of VCG is studied in patients with IHD.
Our published data indicate that on-line VCG changes may predict ischemia in a
predischarge exercise test and are associated with ischemia, as assessed by dobutamine
stress echocardiography, and can be interpreted with low inter- and intra-observer
variations. Resent studies using VCG-monitoring during PTCA indicate that VCG monitoring during elective PCI is a promising method for immediate detection of patients with increased risk for procedure-related MI and may identify patients at increased risk of early (within 6 months) revascularization.
In patients with unstable angina pectoris and acute myocardial infarction,
on-line VCG provides independent prognostic information. We are now the "core lab" for VCG in several intenational multicenter
trials. More information at KI |
| Echocardiography in ischemic heart disease |
We have more than 15 years experience in using echocardiography and Doppler (Echo-Doppler) in scientific studies, involving a large number of diseases such as ischemic heart disease (IHD), heart failure (HF), stroke and hypertension. We have experience in working with Echo-Doppler as "core lab" in several large multi-center trials. Our main interest has been in patients with IHD and HF. The effects of treatment with ACE-inhibition, beta-blocker and calcium channel antagonist on left ventricular function have been evaluated in different trials. More information at KI |
Contact information:
Dr Sven V Eriksson
Department of Medicine
Danderyd Hospital
182 88 Danderyd
Sweden
Phone + 46 8 6555 000
Privat Fax + 46 8 622 68 10
e-mail svemed@pi.se
Mobile phone: 070 721 30 60
Send mail to me!
This page changed when necessary.
Back to Karolinska Institutet